Summary by Moomoo AI
Health International Medical Group Limited announced that it will extend the schedule of use of the net proceeds from the investment program, originally scheduled to be completed by the end of 2023, to the end of 2026. The decision concerned HK$247 million net of first income and HK$996 million for second income. The Company stated that the postponement will more effectively meet business and operational needs and meet the overall interests of the Company and its shareholders. The move is to adopt a more cautious investment and development strategy in light of the slowdown in global economic growth and financial pressures on healthcare providers following the pandemic. The Board considers the extension of the operating schedule to be an appropriate and prudent decision.